Table 1 SHCS Patient Characteristics
| HIV+ w/o HL group (n = 10) | HIV+ HL+ group (n = 10) | w/o HL vs. HL+ (p-value) | |
|---|---|---|---|
| Gender | |||
| Male | 10 | 10 | NA |
| Ethnicity | |||
| Caucasian | 10 | 10 | NA |
| Age at HIV diagnosis, median (IQR) | 34.5 (28.75, 38) | 31 (26.75, 39) | 0.1211 |
| Baseline plasma viral load (copies per ml), median (IQR) | 25,865 (11,730, 51,475) | 24,092 (14,550, 739,500) | 0.1602 |
| Baseline CD4+ T cell count per ul, median (IQR) | 523 (368, 602) | 448 (310, 526) | 0.3750 |
| Years between HIV diagnosis and initiation of cART, median (IQR) | 3 (1.5, 3.25) | 2 (0, 2.5) | 0.4688 |
| Duration cART in days, median (IQR) | 976 (717, 1457) | 1382 (568, 2328) | 0.3750 |
| cART included EFV (%) | 30% | 60% | 0.3698i |
|
Age at HL diagnosis, median (IQR) | NA | 39 (34, 44.25) | |